In a SphK2 knockout (SphK2−/−) mouse model, we revealed that CS-induced pulmonary inflammation and fibrosis were significantly decreased, and SphK2 deficiency rescued CFTR activity and preserved pulmonary function by suppressing the S1P secretion. This evidence concerns the gene CFTR and inflammatory response.